Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Osteoarthritis Cartilage. 2022 Jan 11;30(4):559–569. doi: 10.1016/j.joca.2021.12.010

Figure 1. Secular Trend of Prevalence of Prescription of (A) Overall PPI and H2RA, and (B) Omeprazole, Pantoprazole, Lansoprazole, Rabeprazole, and Esomeprazole, among Patients with Knee Osteoarthritis in The Health Improvement Network Database.

Figure 1.

Figure 1.

OA, osteoarthritis; PPI, proton pump inhibitor; H2RA, Histamine-2 receptor antagonist.